StockWatch
·
Pharmaceuticals
Quarterly Result16 Oct 2026, 01:40 pm

Solara Active Pharma Sciences Declares Unaudited Q2 FY27 Results

AI Summary

Solara Active Pharma Sciences Limited announced that its Board of Directors has approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The results were reviewed by statutory auditors M/s. Deloitte Haskins & Sells LLP. The financial information will be available on the company's investor relations website.

Key Highlights

  • Board approved unaudited standalone and consolidated financial results.
  • Results are for the quarter and half year ended September 30, 2026.
  • Financial results were subject to a limited review by auditors.
  • Results will be available on the company's website.
  • The Board meeting was held on October 16, 2026.